Skip to main content

Peripheral Artery Disease: An Overview

  • Chapter
  • First Online:
  • 773 Accesses

Abstract

Lower extremity peripheral artery disease (PAD) now affects approximately 200 million men and women worldwide and 8 million people in the United States. The prevalence of PAD increases with older age. PAD will be increasingly common as the population lives longer with chronic disease. Although the most classic symptom of PAD is intermittent claudication, most people with PAD do not have classic intermittent claudication, and many people with PAD report no exertional leg symptoms, in part because people with PAD have restricted their activity to avoid leg symptoms. For these reasons, PAD is frequently underdiagnosed. The therapeutic approach to PAD consists of medical therapies to prevent cardiovascular events and exercise interventions to improve walking ability and prevent mobility loss.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–40.

    Article  Google Scholar 

  2. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.

    Article  Google Scholar 

  3. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286(13):1599–606.

    Article  CAS  Google Scholar 

  4. McDermott MM, Applegate WB, Bonds DE, Buford TW, Church T, Espeland MA, et al. Ankle brachial index values, leg symptoms, and functional performance among community-dwelling older men and women in the lifestyle interventions and independence for elders study. J Am Heart Assoc. 2013;2(6):e000257.

    Article  Google Scholar 

  5. McDermott MM. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res. 2015;116(9):1540–50.

    Article  Google Scholar 

  6. McDermott MM, Liu K, Criqui MH, Ruth K, Goff D, Saad MF, et al. Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2005;162(1):33–41.

    Article  Google Scholar 

  7. Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-ethnic study of atherosclerosis). J Am Coll Cardiol. 2010;56(18):1506–12.

    Article  Google Scholar 

  8. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509–26.

    Article  CAS  Google Scholar 

  9. Allison MA, Ho E, Denenberg JO, Langer RD, Newman AB, Fabsitz RR, et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32(4):328–33.

    Article  Google Scholar 

  10. Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh artery study. Am J Epidemiol. 1992;135(4):331–40.

    Article  CAS  Google Scholar 

  11. Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk. 1994;1(4):333–9.

    Article  CAS  Google Scholar 

  12. Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease. JAMA. 2012;308(16):1660–7.

    Article  CAS  Google Scholar 

  13. Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24(8):1433–7.

    Article  CAS  Google Scholar 

  14. Haltmayer M, Mueller T, Horvath W, Luft C, Poelz W, Haidinger D. Impact of atherosclerotic risk factors on the anatomical distribution of peripheral arterial disease. Int Angiol. 2001;20(3):200–7.

    CAS  PubMed  Google Scholar 

  15. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a measure of atherosclerosis in the Cardiovascular Health Study(CHS) Collaborative Research Group. Circulation. 1993;88(3):837–45.

    Article  CAS  Google Scholar 

  16. McDermott MM, Fried L, Simonsick E, Ling S, Guralnik JM. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the Women’s Health and Aging Study. Circulation. 2000;101(9):1007–12.

    Article  CAS  Google Scholar 

  17. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ. 1962;27:645–58.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Criqui MH, Denenberg JO, Bird CE, Fronek A, Klauber MR, Langer RD. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med. 1996;1(1):65–71.

    Article  CAS  Google Scholar 

  19. McDermott MM, Greenland P, Liu K, Guralnik JM, Celic L, Criqui MH, et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med. 2002;136(12):873–83.

    Article  Google Scholar 

  20. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890–909.

    Article  Google Scholar 

  21. Lijmer JG, Hunink MGM, van den Dungen JL, Smit AJ. ROC analyses of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol. 1996;22(4):391–8.

    Article  CAS  Google Scholar 

  22. Guo X, Li J, Paang W, Zhao M, Luo Y, Sun Y, et al. Sensitivity and specificity of ankle-brachial index for detecting angiographic stenosis of peripheral arteries. Circ J. 2008;72(4):605–10.

    Article  Google Scholar 

  23. Ouriel K, McDonnell AE, Metz CE, Zarinss CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery. 1982;91(6):686–93.

    CAS  PubMed  Google Scholar 

  24. McDermott MM, Criqui MH, Liu K, Guralnik JM, Greenland P, Martin GJ, et al. Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial pressure, and lower extremity functioning in peripheral arterial disease. J Vasc Surg. 2000;32(6):1164–71.

    Article  CAS  Google Scholar 

  25. Nead KT, Cooke JP, Olin JW, Leeper NJ. Alternative ankle-brachial index method identifies additional at-risk individuals. J Am Coll Cardiol. 2013;62(6):553–9.

    Article  Google Scholar 

  26. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197–208.

    Article  Google Scholar 

  27. McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004;292(4):453–61.

    Article  CAS  Google Scholar 

  28. McDermott MM, Guralnik JM, Tian L, Liu K, Ferrucci L, Liao Y, et al. Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol. 2009;53(12):1056–62.

    Article  Google Scholar 

  29. McDermott MM, Ferrucci L, Liu K, Guralnik JM, Tian L, Liao Y, et al. Leg symptom categories and rates of mobility decline in peripheral artery disease. J Am Geriatr Soc. 2010;58(7):1256–62.

    Article  Google Scholar 

  30. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC guideline on the management of patients with peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2017;135:e686–785.

    PubMed  Google Scholar 

  31. Hess CN, Hiatt WR. Antithrombotic therapy for peripheral artery disease in 2018. JAMA. 2018;319(22):2329–30.

    Article  Google Scholar 

  32. McDermott MM. Exercise rehabilitation for peripheral artery disease: a review. J Cardiopulm Rehabil Prev. 2018;38(2):63–9.

    Article  Google Scholar 

  33. McDermott MM. Medical management of functional impairment in peripheral artery disease: a review. Prog Cardiovasc Dis. 2018;60(6):586–92.

    Article  Google Scholar 

  34. McDermott MM. Exercise training for intermittent claudication. J Vasc Surg. 2017;66(5):1612–20.

    Article  Google Scholar 

  35. Harwood AE, Smith GE, Cayton T, Broadbent E, Chetter IC. A systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication. Ann Vasc Surg. 2016;34:280–9.

    Article  Google Scholar 

  36. McDermott MM, Kibbe MR, Guralnik JM, Ferrucci L, Criqui MH, Domanchuk K, et al. Durability of benefits from supervised treadmill exercise in patients with peripheral artery disease. J Am Heart Assoc. 2019;8(1):e009380.

    Article  Google Scholar 

  37. McDermott MM, Spring B, Berger JS, Treat-Jacobson D, Conte MS, Creager MA, et al. Effect of a home-based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease: the HONOR Randomized Clinical Trial. JAMA. 2018;319(16):1665–76.

    Article  Google Scholar 

  38. McDermott MM, Ferrucci L, Tian L, Guralnik JM, Lloyd-Jones D, Kibbe MR, et al. Effect of granulocyte-macrophage colony-stimulating factor with or without supervised exercise on walking performance in patients with peripheral artery disease: the PROPEL randomized clinical trial. JAMA. 2017;318(21):2089–98.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mary M. McDermott .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

McDermott, M.M. (2020). Peripheral Artery Disease: An Overview. In: Yuan, C., Hatsukami, T., Mossa-Basha, M. (eds) Vessel Based Imaging Techniques . Springer, Cham. https://doi.org/10.1007/978-3-030-25249-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25249-6_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25248-9

  • Online ISBN: 978-3-030-25249-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics